Shanghai Shyndec Pharmaceutical News

Announcement Regarding Retirement and Departure of Senior Management.

Jul 17 12:00 ET

Investor Relations Activity Record Form.

Jul 15 05:27 ET

CITIC Securities Co., Ltd.'s verification opinion on the non-publicly issued restricted shares of Shanghai Modern Pharmaceutical Co., Ltd. for listing and circulation.

Jul 7 12:00 ET

Voluntary information disclosure announcement regarding the consistency evaluation of pharmaceuticals through generic drugs.

Jun 3 12:00 ET

Independent director system

May 28 12:00 ET

Announcement on holding the results briefing for the first quarter of 2023 and 2024

May 9 12:00 ET

Announcement on the acquisition of CEP certification for APIs from Wholly-owned Sun Company

Apr 29 12:00 ET

Announcement of Resolutions of the 13th Meeting of the Eighth Board of Directors

Apr 29 12:00 ET

Announcement of Resolutions of the Eighth Meeting of the Eighth Board of Supervisors

Apr 29 12:00 ET

Investor Relations Activity Record Form

Apr 23 21:35 ET

CITIC Securities Co., Ltd.'s 2023 Continued Supervision Report on Shanghai Modern Pharmaceutical Co., Ltd.

Apr 9 12:00 ET

CITIC Securities Co., Ltd. site inspection report on Shanghai Hyundai Pharmaceutical Co., Ltd.'s 2023 continuous supervision work site

Apr 9 12:00 ET

2023 Consolidated Audit Report

Mar 29 12:00 ET

Independent Director's 2023 Debriefing Report (Li Yingqi)

Mar 29 12:00 ET

2023 Environmental, Social Responsibility and Corporate Governance (ESG) Report

Mar 29 12:00 ET

2023 Internal Control Audit Report

Mar 29 12:00 ET

Independent Director's 2023 Debriefing Report (Tian Kan)

Mar 29 12:00 ET

Independent Director's 2023 Debriefing Report (Wu Fanhong)

Mar 29 12:00 ET

CITIC Securities Co., Ltd.'s inspection opinion on the 2024 daily related transaction forecast of Shanghai Modern Pharmaceutical Co., Ltd.

Mar 29 12:00 ET

2023 Special Audit Instructions for Non-operating Capital Occupation and Other Related Fund Transactions

Mar 29 12:00 ET